Precigen (PGEN) Change in Inventory (2014 - 2026)

Precigen (PGEN) posted quarterly Change in Inventory of $4.9 million for Q1 2026, down 22.07% quarter-over-quarter from $6.3 million in Q4 2025.

Precigen (PGEN) Change in Inventory (2014 - 2026) Analysis & Trends

Precigen (PGEN) has reported Change in Inventory for 11 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.

In Q1 2026, Change in Inventory changed N/A year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $11.1 million (up 808.65% YoY), while the FY2025 annual figure was $9.2 million, changed N/A from the prior year.
Change in Inventory eased to $4.9 million in Q1 2026 per PGEN's latest filing, from $6.3 million in the prior quarter.
Across five years, Change in Inventory topped out at $6.3 million in Q4 2025 and bottomed at -$1.6 million in Q3 2022.
Historically, Change in Inventory has averaged $1.5 million across 3 years, with a median of -$85500.0 in 2022.
On a YoY basis, Change in Inventory climbed as much as 26.35% in 2022 and fell as far as 130.71% in 2022.
Precigen's Change in Inventory stood at $67000.0 in 2022, then surged by 9244.78% to $6.3 million in 2025, then declined by 22.07% to $4.9 million in 2026.
Business Quant data shows PGEN's Change in Inventory at $4.9 million in Q1 2026, $6.3 million in Q4 2025, and $67000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	27.70 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	28.20 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	47.15 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-2,188.52
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-280,000.00
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	12.97 Mn
10	Precigen	2.18 Bn	2.18 Bn	52.17 Mn	5.79 Mn

Download Data